Markus Weber

11.5k total citations · 2 hit papers
134 papers, 4.9k citations indexed

About

Markus Weber is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Markus Weber has authored 134 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Neurology, 36 papers in Genetics and 26 papers in Molecular Biology. Recurrent topics in Markus Weber's work include Amyotrophic Lateral Sclerosis Research (65 papers), Neurogenetic and Muscular Disorders Research (35 papers) and Parkinson's Disease Mechanisms and Treatments (29 papers). Markus Weber is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (65 papers), Neurogenetic and Muscular Disorders Research (35 papers) and Parkinson's Disease Mechanisms and Treatments (29 papers). Markus Weber collaborates with scholars based in Switzerland, Germany and United States. Markus Weber's co-authors include Andrew Eisen, Christoph Neuwirth, Peter M. Andersen, Vincenzo Silani, Mamede de Carvalho, Andreas Sommacal, Susanne Petri, Katja Kollewe, Christian Burkhardt and Adriano Chiò and has published in prestigious journals such as Physical Review Letters, Nucleic Acids Research and Physical review. B, Condensed matter.

In The Last Decade

Markus Weber

129 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force

2011 788 citations Peter M. Andersen, Gian Domenico Borasio et al. European Journal of Neurology profile →
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)

2024 43 citations Philip Van Damme, Ammar Al‐Chalabi et al. European Journal of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Weber Switzerland	37	2.9k	1.7k	1.1k	692	548	134	4.9k
Lorne Zinman Canada	37	3.0k 1.0×	1.4k 0.8×	1.3k 1.1×	508 0.7×	437 0.8×	126	4.6k
Roland G. Henry United States	57	1.7k 0.6×	985 0.6×	1.4k 1.2×	465 0.7×	852 1.6×	153	10.1k
Safa Al‐Sarraj United Kingdom	47	3.3k 1.1×	1.4k 0.8×	3.2k 2.8×	809 1.2×	1.2k 2.1×	145	7.6k
Siddharthan Chandran United Kingdom	47	3.4k 1.2×	2.3k 1.3×	4.4k 3.8×	1.6k 2.3×	1.3k 2.4×	204	9.0k
Amami Kato Japan	40	1.3k 0.5×	677 0.4×	1.2k 1.0×	1.6k 2.3×	733 1.3×	244	6.0k
Nobuhito Saito Japan	46	3.0k 1.0×	1.3k 0.7×	2.1k 1.9×	976 1.4×	520 0.9×	520	9.2k
I. Berry France	42	1.3k 0.5×	466 0.3×	914 0.8×	411 0.6×	687 1.3×	184	6.5k
Rebecca D. Folkerth United States	49	1.5k 0.5×	786 0.5×	1.9k 1.6×	988 1.4×	665 1.2×	135	8.2k
Matilde Inglese Italy	55	2.9k 1.0×	309 0.2×	1.1k 1.0×	542 0.8×	812 1.5×	290	10.3k
Bauke M. de Jong Netherlands	50	1.7k 0.6×	272 0.2×	2.2k 1.9×	675 1.0×	511 0.9×	304	8.1k

Countries citing papers authored by Markus Weber

Since Specialization

Citations

This map shows the geographic impact of Markus Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Weber more than expected).

Fields of papers citing papers by Markus Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Weber. The network helps show where Markus Weber may publish in the future.

Co-authorship network of co-authors of Markus Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Weber. A scholar is included among the top collaborators of Markus Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Weber. Markus Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weidensteiner, Claudia, Laura Sander, Matthias Weigel, et al.. (2025). Spinal cord gray matter atrophy is associated with disability in spinal muscular atrophy. Journal of Neurology. 272(1). 102–102. 1 indexed citations

Damme, Philip Van, Ammar Al‐Chalabi, Peter M. Andersen, et al.. (2024). European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD). European Journal of Neurology. 31(6). e16264–e16264. 43 indexed citations breakdown →

Sánchez‐Taltavull, Daniel, Franziska Tschan, Norbert K. Semmer, et al.. (2024). Noise in the operating room coincides with surgical difficulty. BJS Open. 8(5). 3 indexed citations

Hitzenbichler, Florian, et al.. (2023). Infection image: reoccurrence of Kaposi`s sarcoma after SARS-CoV-2 mRNA vaccination in an HIV-infected patient. Infection. 52(1). 283–284. 2 indexed citations

Maier, Marcel, Tobias Welt, Fabio Montrasio, et al.. (2018). A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Science Translational Medicine. 10(470). 58 indexed citations

Noristani, Harun N., Yannick N. Gerber, Marisa Teigell, et al.. (2015). Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS. Molecular Neurodegeneration. 10(1). 34–34. 29 indexed citations

Weber, Markus, et al.. (2014). Diagnostic et traitement du cancer différencié de la thyroïde. Forum Médical Suisse ‒ Swiss Medical Forum. 14(9).

Weber, Markus, et al.. (2013). Attitudes towards hastened death in ALS: A prospective study of patients and family caregivers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(1-2). 68–76. 60 indexed citations

Czell, David, Peter M. Andersen, Christoph Neuwirth, Mitsuya Morita, & Markus Weber. (2013). Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(2). 138–140. 10 indexed citations

10.

Bauer, Michael, et al.. (2012). Limitations of Sniff Nasal Pressure as an Outcome Measurement in Amyotrophic Lateral Sclerosis Patients in a Clinical Trial. Respiration. 84(4). 306–311. 13 indexed citations

11.

Czell, David, Matthias Bauer, Janek Binek, Otto D. Schoch, & Markus Weber. (2012). Outcomes of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Noninvasive Ventilation. Respiratory Care. 58(5). 838–844. 38 indexed citations

12.

Lange, Leslie A., Caroline Ingre, Markus Weber, et al.. (2011). Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Human Molecular Genetics. 20(9). 1697–1700. 113 indexed citations

13.

Schinko, Johannes B., Markus Weber, Ivana Viktorinová, et al.. (2010). Functionality of the GAL4/UAS system in Tribolium requires the use of endogenous core promoters. BMC Developmental Biology. 10(1). 53–53. 72 indexed citations

14.

Weber, Markus, et al.. (2010). Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. Journal of Neurology Neurosurgery & Psychiatry. 81(10). 1135–1140. 80 indexed citations

15.

Colombrita, Claudia, Eleonora Zennaro, Claudia Fallini, et al.. (2009). TDP‐43 is recruited to stress granules in conditions of oxidative insult. Journal of Neurochemistry. 111(4). 1051–1061. 416 indexed citations

16.

Weber, Markus, Vanessa M. Ferreira, & Andrew Eisen. (2009). Determinants of double discharges in amyotrophic lateral sclerosis and Kennedy disease. Clinical Neurophysiology. 120(11). 1971–1977. 13 indexed citations

17.

Weber, Markus. (2008). Meeting report of European ALS Consortium (EALSC): 6^thEuropean ALS congress research workshop and young investigators’ meeting. Amyotrophic Lateral Sclerosis. 9(5). 318–320. 1 indexed citations

18.

Saucke, Karen, Markus Weber, Christian Kurtsiefer, Harald Weinfurter, & Jürgen Volz. (2006). Analysis of a single-atom dipole trap (7 pages). Physical Review A. 73(4). 43406. 10 indexed citations

19.

Stewart, Heather, Peter M. Andersen, Andrew Eisen, & Markus Weber. (2006). Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutations. Clinical Neurophysiology. 117(8). 1850–1861. 13 indexed citations

20.

Czapliński, Adam, Andreas Steck, Peter M. Andersen, & Markus Weber. (2004). Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis. European Journal of Neurology. 11(8). 567–568. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact